Nektar Therapeutics (OQ:NKTR)

Latest 10 SEC filings (by transaction date) for NKTR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 25th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 14/24 Mar 14/24 Deep Track Capital, LP Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 22/24 Feb 20/24 Zalevsky Jonathan Direct Ownership Common Stock S - Open market or private sale -9,014 $0.680
Feb 22/24 Feb 20/24 Wilson Mark Andrew Direct Ownership Common Stock S - Open market or private sale -7,606 $0.680
Feb 22/24 Feb 20/24 Robin Howard W Direct Ownership Common Stock S - Open market or private sale -20,033 $0.680
Dec 15/23 Dec 13/23 Zalevsky Jonathan Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 250,000  
Dec 15/23 Dec 13/23 Wilson Mark Andrew Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 325,000  
Dec 15/23 Dec 13/23 Robin Howard W Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 1,300,000  
Nov 20/23 Nov 17/23 Zalevsky Jonathan Direct Ownership Common Stock S - Open market or private sale -9,646 $0.490
Nov 20/23 Nov 17/23 Wilson Mark Andrew Direct Ownership Common Stock S - Open market or private sale -7,179 $0.490
Nov 20/23 Nov 17/23 Robin Howard W Direct Ownership Common Stock S - Open market or private sale -19,877 $0.490
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for NKTR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 25th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 14/24 Mar 14/24 Deep Track Capital, LP Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 22/24 Feb 20/24 Zalevsky Jonathan Direct Ownership Common Stock S - Open market or private sale -9,014 $0.680
Feb 22/24 Feb 20/24 Wilson Mark Andrew Direct Ownership Common Stock S - Open market or private sale -7,606 $0.680
Feb 22/24 Feb 20/24 Robin Howard W Direct Ownership Common Stock S - Open market or private sale -20,033 $0.680
Dec 15/23 Dec 13/23 Zalevsky Jonathan Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 250,000  
Dec 15/23 Dec 13/23 Wilson Mark Andrew Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 325,000  
Dec 15/23 Dec 13/23 Robin Howard W Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 1,300,000  
Nov 20/23 Nov 17/23 Zalevsky Jonathan Direct Ownership Common Stock S - Open market or private sale -9,646 $0.490
Nov 20/23 Nov 17/23 Wilson Mark Andrew Direct Ownership Common Stock S - Open market or private sale -7,179 $0.490
Nov 20/23 Nov 17/23 Robin Howard W Direct Ownership Common Stock S - Open market or private sale -19,877 $0.490
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $NKTR

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Eyepoint Pharmaceuticals (OQ:EYPT)
AbbVie (N:ABBV)
Merck & Co (N:MRK)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.